-
04-02-2021, 12:03 PM
#18991
Member
http://nzx-prod-s7fsd7f98s.s3-websit...113/339804.pdf
Looks like every option is exercised as they become available. I take it as things are going well in the inside?
-
04-02-2021, 12:19 PM
#18992
Originally Posted by calledone
No brainer - exercise at 51c and sell at $1.00+
-
04-02-2021, 12:29 PM
#18993
Member
Originally Posted by Balance
No brainer - exercise at 51c and sell at $1.00+
Yes but assume it is a good sign if we don't see any sell disclosure in a months time?
Last edited by calledone; 04-02-2021 at 12:32 PM.
-
04-02-2021, 12:41 PM
#18994
Originally Posted by calledone
Yes but assume it is a good sign if we don't see any sell disclosure in a months time?
These are staff options - no disclosure unless they are senior executives or directors.
BTW, I have no issues with staff exercising options and selling them immediately.
It is part of their remuneration & incentive package.
Last edited by Balance; 04-02-2021 at 12:45 PM.
-
04-02-2021, 12:44 PM
#18995
Member
Originally Posted by Balance
These are staff options - no disclosure unless they are senior executives or directors.
Got that, thanks.
-
06-02-2021, 08:35 PM
#18996
Junior Member
their latest clinicial study show better effectiveness vs. current golden standard cystoscopy
-
10-02-2021, 08:59 AM
#18997
Originally Posted by Scotland Tce
their latest clinicial study show better effectiveness vs. current golden standard cystoscopy
That comment prompted me to check out the PEB website. Canterbury DHB’s clinical study was very positive.
-
10-02-2021, 10:10 AM
#18998
Originally Posted by Brain
That comment prompted me to check out the PEB website. Canterbury DHB’s clinical study was very positive.
That news was positive but was also back in December, no updates this year so far so hopefully due something soon. of most interest will be adoption by other overseas entities and what's happening in the USA. PEB took on senior staff to build that market, be great for a report about how this work is progressing (and the collection of historical payments too)
-
10-02-2021, 12:41 PM
#18999
Member
Originally Posted by 850man
That news was positive but was also back in December, no updates this year so far so hopefully due something soon. of most interest will be adoption by other overseas entities and what's happening in the USA. PEB took on senior staff to build that market, be great for a report about how this work is progressing (and the collection of historical payments too)
Very interested in seeing if COVID continues to improve uptake by clinicians (on one hand) vs the impact COVID may or may not be having on the sales pipeline for the larger medical institutions.
-
10-02-2021, 02:00 PM
#19000
Originally Posted by 850man
That news was positive but was also back in December, no updates this year so far so hopefully due something soon. of most interest will be adoption by other overseas entities and what's happening in the USA. PEB took on senior staff to build that market, be great for a report about how this work is progressing (and the collection of historical payments too)
I consider late December to be very recent particularly considering that most people have been on holiday between then and now.
I expect PEB’s price to increase slowly but surely as the technology is adopted over time. I am not looking for any one event to put a rocket under the share price.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks